Blueprint Medicines
Acquired by Sanofi / NASDAQ: BPMC
Precision therapy company striving to improve human health.
Precision therapy company striving to improve human health.
F-Prime Team
Sector
Life SciencesCategory
TherapeuticsLocation
Cambridge, MAInitial Investment
2012Blueprint Medicines (NASDAQ: BPMC) is a precision therapy company striving to improve human health. Blueprint Medicines was acquired by Sanofi in 2025.